Statement Of Financial Position [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166306

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	122,000 EUR	—	—	—	—	—	—	—	—	—	—	24,000 EUR	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	2,944 EUR	—	—	—	—	—	—	—	—	—	—	2,381 EUR	—	—	—	—	—	—	—
Investments in subsidiaries, joint ventures and associates reported in separate financial statements	—	—	4,079 EUR	—	—	—	—	—	—	—	—	—	—	- EUR	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	50,012 EUR	—	—	—	—	—	—	—	—	—	—	64,399 EUR	—	—	205,000 EUR	—	—	—	—
Assets	—	—	63,444 EUR	—	—	—	—	—	—	—	—	—	—	69,182 EUR	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	129,000 EUR	—	—	—	—	—	—	—	—	—	—	129,000 EUR	—	—	—	—	—	—	—
Retained earnings	—	—	54,805 EUR	—	—	—	—	—	—	—	—	—	—	43,226 EUR	—	—	—	—	—	—	—
Share premium	—	—	103,693 EUR	—	—	—	—	—	—	—	—	—	—	103,693 EUR	—	—	—	—	—	—	—
Other reserves	—	—	960,000 EUR	—	—	—	—	—	—	—	—	—	—	1,537 EUR	—	—	—	—	—	—	—
Equity	54,805 EUR	476,000 EUR	48,056 EUR	3,827 EUR	103,693 EUR	2,391 EUR	129,000 EUR	43,226 EUR	129,000 EUR	3,827 EUR	476,000 EUR	103,693 EUR	1,814 EUR	59,059 EUR	493,000 EUR	23,982 EUR	10,188 EUR	36,081 EUR	1,329 EUR	89,000 EUR	- EUR
Liabilities [abstract]
Liabilities	—	—	15,388 EUR	—	—	—	—	—	—	—	—	—	—	10,123 EUR	—	—	—	—	—	—	—
Equity and liabilities	—	—	63,444 EUR	—	—	—	—	—	—	—	—	—	—	69,182 EUR	—	—	—	—	—	—	—